BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11319763)

  • 1. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
    Nakamura M; Saito H; Ebinuma H; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Ishii H
    J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
    Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
    Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
    Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP
    Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
    Zeng XL; Tu ZG
    Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
    Kaneko F; Saito H; Saito Y; Wakabayashi K; Nakamoto N; Tada S; Suzuki H; Tsunematsu S; Kumagai N; Ishii H
    Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
    Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
    Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
    Wang CT; Meng M
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):927-9. PubMed ID: 17650409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
    Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
    Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
    Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells.
    Woo HJ; Lee SJ; Choi BT; Park YM; Choi YH
    Exp Mol Pathol; 2007 Feb; 82(1):77-84. PubMed ID: 16574101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
    Choi YH
    Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.